The Use of Complementary and Alternative Medications by Menopausal Women in South East Queensland. by Gollschewski, Sara et al.
Women’s Health Issues 14 (2004) 165–171  
 
THE USE OF COMPLEMENTARY AND ALTERNATIVE 




Sara Gollschewski, BHSc (Hons)a* 
Debra Anderson, PhDa,  
Helen Skerman, DipTeach, BSc, MSocSca,  
and  
Philippa Lyons-Wall, DipNutrDiet, PhDb  
 
aCentre for Health Research, Queensland University of Technology, Brisbane, Australia  
bSchool of Public Health, Queensland University of  Technology, Brisbane, Australia  
 
Received May 2004; received in revised form July 2004; accepted August 2004  
 
* Address correspondence to: Sara Gollschewski, Centre for 
Health Research, Queensland University of Technology, Kelvin 
Grove Campus, Brisbane, Australia 4059. 
E-mail: s.gollschewski@qut.edu.au  
 
This study aimed to identify the prevalence and types of complementary and alternative 
medications (CAMs) used by women during menopause and explore potential associations 
between CAM use and menopausal symptoms. Analysis was undertaken with 886 randomly 
selected menopausal women aged 47–67 years who participated in a postal questionnaire on 
the menopause experience. The prevalence of CAM use was relatively high (82.5%), with 
nutrition most commonly cited (67%), followed by phytoestrogens (56%), herbal therapies 
(41%), and CAM medications (25%). Multivariate analysis adjusted for confounders revealed 
that women who consumed CAM medications were 17–23% more likely to report anxiety 
(p _ .019) or vasomotor symptoms (p _ .013). Women who used herbal therapies (p _ .009) or 
phytoestrogens (p _ .030) were 13–16% more likely to experience vasomotor symptoms. 
Women who used nutrition were 18% more likely to experience anxiety (p _ .049). These 
results highlight the importance for health professionals to incorporate CAMs into their 
practice to better inform menopausal women of their treatment choices. 
  
Introduction 
Menopause can represent a “choice point,” a time for women to consider ways to improve  
Their current health status and decrease the risk of longterm illnesses (MacLaren & Woods,  
2001; Taylor, 2001). In the context of menopause, complementary and alternative medications  
(CAMs) have the potential to alleviate symptoms as well as improve general health status.  
Yet few studies have been conducted on the use of CAMs among menopausal women,  
Particularly the types, prevalence, and factors associated with CAM use. CAMs can be  
broadly grouped into CAM medications (ingestible) or therapies (non-ingestible) and  
include nutritional supplements, vitamins, and herbal supplements, as well as yoga, meditation, 
naturopathy, exercise, relaxation, and deep breathing (Chopin Lucks, 2003; Gorton,  
1988; Ivarsson, Spetz, & Hammar, 1998; Wijma et al., 1997; Williamson et al., 2002;  
Younus et al., 2003). Studies indicate that the use of CAMs in the general 
population has been increasing although the types of CAMs measured vary widely between  
studies. Eisenberg and colleagues (Eisenberg et al., 1998; Eisenberg et al., 1993), in a  
follow-up telephone survey of adult Americans, reported that visits to an alternative  
practitioner increased from 36–46% between 1991 and 1997, with a 65% increase in the  
total number of therapies used. In a survey of Australian adults in 1996, 49% reported  
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using at least one CAM, with 19% using two or more. Of those who used CAMs, 38% used 
 vitamins, 10% herbal therapies, and 4% evening primrose oil (MacLennan, Wilson, &  
Taylor, 1996). Surveys on the use of CAMs in Australian (MacLennan, Wilson, & Taylor,  
1996) or American (Eisenberg et al., 1998; Eisenberg et al., 1993) adults have further 
indicated that females used significantly more CAMs than males, especially women who  
were middle-aged and Caucasian. 
 
 
In relation to menopausal symptoms such as hot flushes, studies have been undertaken on  
the clinical effectiveness of phytoestrogens (Albertazzi et al., 1998; Dalais et al., 1998;  
Drapier Faure, Chantre, & Mares, 2002; van de Weijer & Barentsen, 2002) and herbal 
therapies such as Chinese herbs (Davis et al., 2001), dong quai (Hirata et al., 1997), and  
evening primrose oil (Chenoy et al., 1994). The effect of nutritional supplements such as  
calcium on postmenopausal bone loss has also been explored (Aloia et al., 1994;  
Dawson-Hughes et al., 1990; Reid et al., 1993). However, few studies have measured  
the use of CAMs in association with symptoms in a population-based sample of  
menopausal women, specifically types and prevalence of use. A study of 886 American  
women aged 45–65 years measured CAMs taken to treat menopausal symptoms (Newton  
et al., 2002). Eight types of CAMs were explored including dietary soy products, acupuncture,  
massage therapy, relaxation, chiropractic, visits to herbalists, visits to homeopathic/ 
naturopathies, and natural remedies. A total of 22% had used CAMs specifically to treat  
menopausal symptoms; the three most commonly cited were natural therapies, including  
herbal and naturopathic remedies (13%), followed by relaxation (9%) and dietary soy  
supplements (7%). In the Seattle Midlife Women’s Health Study, a study of women aged  
42–61 years, 10% used exercise and yoga to treat depression and although CAM use was  
low, women indicated that they were “very” or a “bit effective” (Mitchell, Woods, & Mariella,  
2000). A study of 207 Australian women aged 45–54 years investigated the use of selected 
CAMs and found that 61% of women ate healthy foods and 61% participated in regular physical  
Activity to improve their health (Anderson & Posner, 2002). In a further study on the use of  
CAMs by Australian women, 14% used CAMs to address menopausal symptoms (Biddle,  
Wilkinson, & Simpson, 2003). The aims of this study were (1) to determine the types and  
prevalence of CAMs used during the menopause in a population-based sample of Australian 





This study was a cross-sectional survey of women living in South East Queensland. Ethical  
approval was granted by Queensland University of Technology Human Ethics Committee.  
The sample was randomly selected from the electoral roll during 2001 on the basis of three  
factors: age, gender and postcode. Women were eligible for the study if they were aged 
45–60 years and lived within one of six postcodes, which were selected to ensure that the  
sample represented urban and rural areas and women of varying socioeconomic status. This 
 initial procedure identified 10,923 and from this sample; 1,500 women were randomly invited  
to participate in the study. The response rate among eligible women was 59%. 
 
Data collection 
The primary source of data was generated from the Queensland Midlife Women’s Health Study,  
based on an original questionnaire designed by Anderson and Courtney (Anderson, 1998).  
Participants were sent a 73-item postal questionnaire that contained sections on sociodemographic  
characteristics, menopausal status, general health, menopausal symptoms, and use of prescribed  
and nonprescribed medications, including CAMs. Items for this analysis included menopausal 
symptoms, demographics, and types of medications used during menopause. Menopausal  
symptoms were measured using the Greene Climacteric Scale, a standard measure of climacteric  
symptoms that has been validated in menopausal women (Greene, 1998). This tool measures  
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vasomotor symptoms, which are directly related to a decrease in estrogen, and psychological 
and somatic symptoms, which can have a negative impact on quality of life during the  
menopause transition. The scale comprised 21 symptoms that can be grouped into four  
clusters: psychological,  with subscales of anxiety and depression; somatic; vasomotor; and  
loss of interest in sex. Subjects registered the severity of the symptoms on a scale ranging  
from “not at all,” “a little,” “quite a bit,” to “extremely.” The scale has been used in previous  
studies to measure menopausal symptoms (Barentsen et al., 2001; Canney & Hatton, 1994;  
Chen et al., 2003; van de Weijer & Barentsen, 2002). Menopausal status was determined by  
Questions relating to menstrual history, and women were grouped into four categories:  
premenopausal, no irregularity in the past year and had menstruated in previous 3 months;  
perimenopausal, irregular menstruation over previous year but had menstruated in past 3  
months, or irregular menstruation over previous year but no menstruation in past 3 months; 
postmenopausal, did not menstruate in the previous year; and surgical menopause,  
hysterectomy, and/or a bilateral oophorectomy. Specific details were requested on use of  
non-prescription medications or herbal preparations. Questions were included on use ever  
of dietary and supplemental phytoestrogens and herbal therapies (e.g., black cohosh) and the  
use of dietary supplements (e.g., vitamins and minerals) over the previous month. Women  
were asked to specify the product and brand name, dose and frequency of use, reasons for  
use, and whether it was beneficial during the menopausal transition.  Questions were also  
asked on use ever of strategies used to improve health, including healthy eating. 
 
Data analysis 
Data from the questionnaire were grouped into four types of CAMs for statistical analysis:  
(1) unspecified CAM medications; (2) herbal therapies such as black cohosh and dong quai;  
(3) phytoestrogens including soy or linseed products and soy supplements; and  
(4) nutrition including supplements and healthy eating. 
Frequencies were used to describe the characteristics of the sample. Unadjusted odds ratios  
were used to identify associations between CAMs and menopausal symptoms. These  
relationships were investigated at the multivariate level using binary logistic regression 
after adjustment for smoking, selected demographics including age, postcode, education  
level, income and employment status, hormone replacement therapy (HRT) use, and  
menopause status. For the Greene Climacteric Scale, mean scores were calculated from 
the sum of individual symptoms: psychological and the subscales of anxiety and depression,  
somatic, vasomotor, and loss of interest in sex (Greene, 1998). Statistical Package for Social  
Science (SPSS version 10) was used for statistical analysis. Symptoms scores are presented as 
 means (SD) and associations between CAM use and symptoms are presented as odds ratios 
[95% CI]. Statistical significance for the study was p  .05. 
 
 






Characteristics of the sample  
Sociodemographic characteristics of the sample are shown in Table 1. The total sample  
comprised 886 women aged 47–67 years with a mean of 54.8 years. The majority of  
women were perimenopause, postmenopause, or surgically menopause (92.1%), married 
or in a de facto relationship (76.2%), and cited Australia as their country of origin (82.3%).  
Just over half of the sample had completed less than 10 years of education (56.1%). Just  
under half of the sample resided in rural areas (42.7%), were not in paid employment 
(42.4%), and were current users of HRT (34.7%). Use of complementary and alternative  
medications. 
 
Prevalence of CAM use in the sample is shown in Table 2. Analysis indicated that 82.5%  
of  women used at least one type of CAM. The most commonly reported CAM group was  
nutrition (66.8%), followed by phytoestrogens (55.8%), herbal therapies (41.3%), and 
CAM medications (25.1%). Of the women who used herbal therapies, evening primrose oil  
was the most commonly cited (34.0%), followed by vitamin E (28.8%) and ginseng (13.3%). 
 






Prevalence of menopausal symptoms 
The 21 menopausal symptoms and their perceived severity are listed in Table 3. For all symptoms  
listed, the majority of women reported either “not at all” or “a little” in severity. In the combined  
severity categories of “quite at bit” and “extremely,” the most frequently cited symptoms were loss  
of interest in sex (34.5%), muscle and joint pains (29.2%), feeling tired (25.7%), and difficulty in  
sleeping (25.0%); followed by hot flushes (15.0%), feeling tense (13.2%), and difficulty 
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in concentrating or sweating at night (both 12.5%). The prevalence of other symptoms in  
these combined severity categories was less than 10%. For grouped symptoms, the mean (SD)  
scores were 6.67 (4.79) for psychological symptoms with individual scores of 3.49 (2.65) for  
anxiety and 3.04 (2.49) for depression; 3.48 (2.90) for somatic symptoms, 1.18 (1.50) for  
vasomotor symptoms, and 1.19 (1.00) for sexual dysfunction. Grouped scores for the current 
study are compared with previous data from Dutch (Barentsen et al., 2001) and Taiwanese  
(Chen et al., 2003) women in Table 4. 
 
Menopausal symptoms and CAM use 
Statistically significant associations were evident between CAMs and menopausal symptoms.  
women who consumed an unspecified CAM medications were significantly more likely to  
have experienced anxiety, OR  1.23 [1.04 –1.47] (p  .019) or vasomotor symptoms, OR  
 1.17 [1.03–1.32], p  .013). Women who used herbal therapies, OR  1.16 [1.04 –1.29]  
(p  .009) or phytoestrogens, OR  1.14 [1.01–1.27] (p  .030) were more likely to have 
experienced vasomotor symptoms. Women who used nutrition were more likely to experience  
anxiety, OR  1.18 [1.00 –1.38] (p  .049). These associations remained significant with  





Complementary and alternative medications have the potential to alleviate symptoms of  
menopause as well as improve health status. Previous studies have explored CAM intake in  
the general  population (Eisenberg et al., 1998; MacLennan et al., 1996), in women aged 15–60  
years for reproductive conditions (Biddle et al., 2003), explored a limited range of CAMS 
(Anderson & Posner, 2002; Mitchell et al., 2000), or have given a preliminary indication of the  
types used during menopause (Newton et al., 2002). Yet few studies exist on the use of CAMs  
during the menopausal period. This study was conducted to address this issue and determine the  
prevalence of use of selected CAMs and associated symptoms in women undergoing the  
menopausal transition. The first aim was to explore the types and prevalence of CAM use  
during menopause. Eight hundred eighty-six women aged 47–67 years randomly selected 
from the electoral roll in South East Queensland completed a postal questionnaire on the  
menopause experience. Overall, 82.5% of the sample reported using at least one group of  
CAMs. The most commonly reported was nutrition (66.8%), based on use of dietary supplements  
and healthy eating. Fifty-six percent of women reported using phytoestrogens, by including soy  
or linseed products in their diet (61%) or as supplements (33%); 41% of women stated that they 
used at least one herbal therapy, with evening primrose oil most commonly cited (34%).  
Twenty-five percent of women reported using CAM medications (25.1%), based on  
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use of any nonprescription medication or herbal preparation. The prevalence of CAM use  
in this Australian study was higher than previously reported in a study of 886 
menopausal American women, where only 13% of women reported using remedies such as  
herbal therapies and 7% reported using phytoestrogens (Newton et al., 2002). However,  
further comparisons are limited due to differences in the range of CAMs measured. CAM  
use was also higher than that reported in two previous Australian studies: in women aged  
15–60 years with reproductive conditions, 14% reported using CAMs to address menopausal  
symptoms (Biddle et al., 2003); and in the general population, 38% used vitamins, 10%  
herbal therapies, and 4% used evening primrose oil (MacLennan et al., 1996). However, this 
study included adult males and females over 15 years and did not focus specifically on the  
menopausal transition (MacLennan et al., 1996). The results of this study also indicated that  
women used multiple forms of herbal therapies during menopause. The prevalence of  
menopause symptoms in this study indicated that most women do not experience symptoms;  
however, if experienced, the severity of symptoms was reported as causing only a “little 
concern.” Vasomotor symptoms such as sweating at night and hot flushes were not experienced  
by the majority (62% and 55%, respectively), and women who experienced these symptoms  
cited the severity as “a little” (26% and 30%, respectively). The overall frequency of hot flushes  
(combining “a little,” “quite a bit,” and “extremely”) is comparable to a previous Australian  
study (40%) (Dennerstein et al., 1993), lower than the United States (76%) (Staropoli et al., 
1998) and Canada (65%) (Lock, 1994) and higher than Thailand (27%) (Punyahotra, Dennerstein,  
& Lehert, 1997) and Japan (20%) (Lock, 1994). The mean scores for psychological, somatic,  
vasomotor, and loss of interest in sex were comparable to the scores previously reported in samples  
of menopausal women aged 45–65 years in Taiwan (Chen et al., 2003) and Holland (Barentsen et  
al., 2001) (Table 4). The mean somatic score in Taiwanese women was higher than in our sample,  
which supports previous research in which women from Asian countries are more likely to  
experience somatic symptoms, such as stiff shoulders and backaches (Im, Meleis, & Lee, 1999;  
Lock, 1994). For vasomotor symptoms, the mean score for this study was lower than previous  
studies; however, this finding is not supported by previous literature that indicated Western women  
were more likely than Asian women to experience vasomotor symptoms (Lock, 1986; Lock, 1994;  
Mishra et al., 2002). The second aim of this study was to identify possible associations between  
CAM use and menopausal symptoms. After adjusting for confounding variables, multivariate  
analyses indicated that use of CAMs was associated with occurrence of two clusters of symptoms: 
vasomotor, which included hot flushes and sweating at night, and anxiety, which included feeling 
tense or nervous, attacks of panic, and difficulty sleeping. Women who used phytoestrogens  
(p  .030) or herbal therapies (p  .049) or unspecified CAM medications (p  .019) were  
13–17% more likely than asymptomatic women to report vasomotor symptoms. Phytoestrogens  
included those consumed in the diet, such as soy or linseed products, or as supplements; herbals  
were defined as eight commonly available products, including wild yam cream, dong quai, 
evening primrose oil, ginseng, and red clover. Due to small numbers in each category, our study  
was unable to distinguish which products were responsible for these associations. Women who  
used unspecified CAM medications (p  .013) or elected to use a nutritional supplement or 
healthy diet (p  .009) were 18–23% more likely to experience increased anxiety. In our study,  
moderate to severe vasomotor symptoms were experienced by 12–15% of the women, while  
moderate to severe anxiety symptoms were experienced by 5–25% of the women. More  
frequently cited symptoms, including loss of interest in sex, muscle and joint pains, or tiredness,  
were experienced by 25–35% of women in moderate or extreme degree; however, in our study, 
the presence of these symptoms was not associated with CAM use. Significant associations  
between vasomotor symptoms and CAM use were also observed in a previous study by Newton  
et al. (2002), who found that women experiencing night sweats were 51% more likely to use herbal  
or naturopathic remedies and that women with hot flushes were 74% more likely to use any  
alternative therapy or medication. Newton et al. (2002) also reported that CAM use was associated 
with difficulty in sleeping, which in our study was included as an item in the anxiety cluster of  
symptoms. The current study specifically addressed the use of CAMs by menopausal women.  
One limitation was the focus on CAM medications while therapies such as yoga, meditation, and  
exercise were not explored, nor were practitioners of CAMs, although these have the potential  
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to be utilized by menopausal women to alleviate symptoms. The strengths of this study lie in 
use of a relatively large sample selected from the general population; and the investigation  
of a comprehensive range of the medications, including herbal therapies, phytoestrogens, and  
nutritional supplements, which allowed associations with symptoms to emerge. The results  
suggest that use of CAM medications could be relatively high in this group, especially in women  
experiencing hot flushes or anxiety. The higher intake could reflect a growing use of these 
medications in the broader community, as evidenced in the literature (Eisenberg et al., 1998).  
Further reasons for the high intake can be postulated. In this technological age, women  
increasingly have access to the internet and are potentially more informed regarding their  
options for symptom management. The departure from the concept of menopause as a medical 
condition to menopause as a natural life phase and the notion of holistic health are also possible  
explanations. The data from this research have indicated that menopausal  women use a variety  
of CAMs to treat symptoms. This highlights the importance for health care professionals to be  
aware that women are utilizing a range of CAMs during the menopausal transition. Further  
research is needed to explore the use of CAMs during menopause, particularly the full range of  
medications and therapies used, the reasons for use, and their perceived efficacy in relation to the  
range of symptoms experienced by menopausal women. 
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